ArticleLaboratory investigation; a journal of technical methods and pathology2018

Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9.

Alvin Ho-Kwan Cheung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.